These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 9925358
21. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia. Lu K, Otani H, Yamamura T, Nakao Y, Hattori R, Ninomiya H, Osako M, Imamura H. J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170 [Abstract] [Full Text] [Related]
22. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning. Serejo FC, Rodrigues LF, da Silva Tavares KC, de Carvalho AC, Nascimento JH. J Cardiovasc Pharmacol; 2007 Apr; 49(4):214-20. PubMed ID: 17438406 [Abstract] [Full Text] [Related]
23. Cross-talk among noradrenaline, adenosine and protein kinase C in the mechanisms of ischemic preconditioning in rabbits. Minatoguchi S, Uno Y, Kariya T, Arai M, Wang N, Hashimoto K, Nishida Y, Maruyama R, Takemura G, Fujiwara T, Fujiwara H. J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S39-47. PubMed ID: 12688395 [Abstract] [Full Text] [Related]
25. Atrial natriuretic peptide administered just prior to reperfusion limits infarction in rabbit hearts. Yang XM, Philipp S, Downey JM, Cohen MV. Basic Res Cardiol; 2006 Jul; 101(4):311-8. PubMed ID: 16604440 [Abstract] [Full Text] [Related]
26. Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts. Liu Y, Tsuchida A, Cohen MV, Downey JM. J Mol Cell Cardiol; 1995 Mar; 27(3):883-92. PubMed ID: 7602606 [Abstract] [Full Text] [Related]
27. Repetitive acidosis protects the ischemic heart: implications for mechanisms in preconditioned hearts. Lundmark JA, Trueblood N, Wang LF, Ramasamy R, Schaefer S. J Mol Cell Cardiol; 1999 Apr; 31(4):907-17. PubMed ID: 10329217 [Abstract] [Full Text] [Related]
28. Redox signaling at reperfusion is required for protection from ischemic preconditioning but not from a direct PKC activator. Liu Y, Yang XM, Iliodromitis EK, Kremastinos DT, Dost T, Cohen MV, Downey JM. Basic Res Cardiol; 2008 Jan; 103(1):54-9. PubMed ID: 17999029 [Abstract] [Full Text] [Related]
30. Protein kinase C isoform diversity in preconditioning. Meldrum DR, Cleveland JC, Meng X, Sheridan BC, Gamboni F, Cain BS, Harken AH, Banerjee A. J Surg Res; 1997 Apr; 69(1):183-7. PubMed ID: 9202667 [Abstract] [Full Text] [Related]
31. Allitridum mimics effect of ischemic preconditioning by activation of protein kinase C. Zhang WJ, Shi ZX, Wang BB, Cui YJ, Guo JZ, Li B. Acta Pharmacol Sin; 2001 Feb; 22(2):132-6. PubMed ID: 11741517 [Abstract] [Full Text] [Related]
32. Limitation of infarct size in rabbit hearts by the novel adenosine receptor agonist AMP 579 administered at reperfusion. Xu Z, Yang XM, Cohen MV, Neumann T, Heusch G, Downey JM. J Mol Cell Cardiol; 2000 Dec; 32(12):2339-47. PubMed ID: 11113009 [Abstract] [Full Text] [Related]
33. Pivotal role of NOX-2-containing NADPH oxidase in early ischemic preconditioning. Bell RM, Cave AC, Johar S, Hearse DJ, Shah AM, Shattock MJ. FASEB J; 2005 Dec; 19(14):2037-9. PubMed ID: 16236999 [Abstract] [Full Text] [Related]
34. The anti-infarct effect of an adenosine A1-selective agonist is diminished after prolonged infusion as is the cardioprotective effect of ischaemic preconditioning in rabbit heart. Tsuchida A, Thompson R, Olsson RA, Downey JM. J Mol Cell Cardiol; 1994 Mar; 26(3):303-11. PubMed ID: 8028014 [Abstract] [Full Text] [Related]
35. Ischemia induced activation of heat shock protein 27 kinases and casein kinase 2 in the preconditioned rabbit heart. Kim SO, Baines CP, Critz SD, Pelech SL, Katz S, Downey JM, Cohen MV. Biochem Cell Biol; 1999 Mar; 77(6):559-67. PubMed ID: 10668633 [Abstract] [Full Text] [Related]
36. Activation of alpha1-adrenergic receptor during Ca2+ pre-conditioning elicits strong protection against Ca2+ overload injury via protein kinase C signaling pathway. Wang Y, Ashraf M. J Mol Cell Cardiol; 1998 Nov; 30(11):2423-35. PubMed ID: 9925377 [Abstract] [Full Text] [Related]
37. Adenosine: trigger and mediator of cardioprotection. Cohen MV, Downey JM. Basic Res Cardiol; 2008 May; 103(3):203-15. PubMed ID: 17999026 [Abstract] [Full Text] [Related]
38. Alpha1-receptor or adenosine A1-receptor dependent pathway alone is not sufficient but summation of these pathways is required to achieve an ischaemic preconditioning effect in rabbits. Baba K, Minatoguchi S, Zhang C, Kariya T, Uno Y, Kawai T, Takahashi M, Takemura G, Fujiwara H. Clin Exp Pharmacol Physiol; 2005 Apr; 32(4):263-8. PubMed ID: 15810989 [Abstract] [Full Text] [Related]
39. Mechanisms of delayed preconditioning with A1 adenosine receptor activation in porcine coronary smooth muscle cells. Nayeem MA, Mustafa SJ. Pol J Pharmacol; 2002 Apr; 54(5):443-53. PubMed ID: 12593531 [Abstract] [Full Text] [Related]
40. Pretreatment with an adenosine A1 receptor agonist and lidocaine: a possible alternative to myocardial ischemic preconditioning. Canyon SJ, Dobson GP. J Thorac Cardiovasc Surg; 2005 Aug; 130(2):371-7. PubMed ID: 16077401 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]